Trials / Completed
CompletedNCT01723566
PANORAMA 2 Observational Study
Panorama 2 Medtronic CRDM Implantable Cardiac Device Long Term Registry
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 4,706 (actual)
- Sponsor
- Medtronic Cardiac Rhythm and Heart Failure · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Understanding the clinical practice of treatment of cardiac rhythm disorders all over the world and understanding the clinical outcomes of the treatment with its cardiac rhythm products in real world patient population is essential for Medtronic to be able to effectively develop new products and adjust existing products. In addition Medtronic is committed to monitor the safety of its products throughout the entire life cycle to ensure maximum product reliability. The Panorama 2 registry will enable Medtronic to increase data collection of clinical practice with Medtronic implantable Cardiac Rhythm and Disease Management (CRDM) devices in various regions across the world and on product reliability of its CRDM devices.
Conditions
Timeline
- Start date
- 2012-07-25
- Primary completion
- 2016-10-31
- Completion
- 2016-10-31
- First posted
- 2012-11-08
- Last updated
- 2025-07-03
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT01723566. Inclusion in this directory is not an endorsement.